NCT Number: NCT01867008
Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults
Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Greater Baltimore Medical Center, Baltimore, Maryland, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Eighteen years of age or older at the time of implantation
- Moderate low frequency thresholds up to and including 1000 Hz, severe to profound high frequency (above 3000 Hz) sensorineural hearing loss
- Minimum of 30 days experience with appropriately fit bilateral amplification, fit using the standardized National Acoustics Laboratory (NAL) fitting method described in the Fitting and Use of Hearing Aids section below
- Aided Consonant Nucleus Consonant (CNC) word recognition score (mean of two lists) between 10% and 50%, inclusive in the ear to be implanted
- Aided CNC word recognition score (mean of two lists) in the contralateral ear equal to, or better than, the ear to be implanted but not more than 70%
- Willingness to use bimodal stimulation (i.e., a cochlear implant on one ear and a hearing aid on the contralateral ear) through at least 6-months postactivation
- English spoken as a primary language
Exclusion criteria
- Duration of severe-to-profound hearing loss greater than 30 years
- Congenital hearing loss (for the purpose of this study, onset prior to 2 years-of-age)
- Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator
- Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array
- Conductive overlay of 15 decibels (dB) or greater at two or more frequencies, in the range 500 to 1000 Hz
- Deafness due to lesions of the acoustic nerve or central auditory pathway
- Absence of cochlear development
- Diagnosis of auditory neuropathy
- Active middle-ear infection
- Tympanic membrane perforation in the presence of active middle ear disease
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices as determined by the Investigator
- Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator
- Additional handicaps that would prevent or restrict participation in the audiological evaluations as determined by the Investigator
Treatment and study plan
Primary outcomes
-
Change in Open Set Monosyllabic Word Recognition Score as Measured on a Consonant Nucleus Consonant (CNC) Word Test
Time frame: Preoperative baseline to 6 months postactivation
Performance at 6 months postactivation compared to pre-operative word recognition score (percent correct: 0-100%, where a 0% is the lowest score and a 100% is the highest score)
Sponsors and collaborators
Lead sponsor
Cochlear
Industry
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jun 3, 2013
- Registry last updated
- Jan 25, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes
NCT05219474
Ear Diseases, Hearing Disorders
New York, United States
View Trial DetailsElectrophysiological Study of Interindividual Differences in Speech-understanding Among Cochlear Implant Patients
NCT01805167
Ear Diseases, Hearing Disorders
Nice, France
View Trial DetailsACHIEVE Hearing Intervention Follow-Up Study
NCT05070429
Aging, Ear Diseases
Hagerstown, Maryland, United States
View Trial DetailsRemote Microphone Performance Comparison in Adults With Hearing Loss
NCT07501312
Ear Diseases, Hearing Disorders
Aurora, Illinois, United States
View Trial Details